509 related articles for article (PubMed ID: 30771436)
1. Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis.
Wang L; Li K; Lin X; Yao Z; Wang S; Xiong X; Ning Z; Wang J; Xu X; Jiang Y; Liu D; Chen Y; Zhang D; Zhang H
Cancer Lett; 2019 May; 450():22-31. PubMed ID: 30771436
[TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin mediating PKM2-caspase-8/3-GSDME axis for pyroptosis in esophageal squamous cell carcinoma.
Jiang M; Wu Y; Qi L; Li L; Song D; Gan J; Li Y; Ling X; Song C
Chem Biol Interact; 2021 Dec; 350():109704. PubMed ID: 34655567
[TBL] [Abstract][Full Text] [Related]
3. PELP1 is a novel oncogene in gastric tumorigenesis and negatively regulated by miR-15 family microRNAs.
Ma C; Miao C; Wang C; Song F; Luo M
Cancer Biomark; 2019; 26(1):1-9. PubMed ID: 31322541
[TBL] [Abstract][Full Text] [Related]
4. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
5. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L.
Chen Q; Hou J; Wu Z; Zhao J; Ma D
Pathol Res Pract; 2019 Jul; 215(7):152427. PubMed ID: 31072625
[TBL] [Abstract][Full Text] [Related]
6. Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo.
Liang F; Wang YG; Wang C
Cell Physiol Biochem; 2018; 51(3):1276-1286. PubMed ID: 30481793
[TBL] [Abstract][Full Text] [Related]
7. TNF‑α‑mediated upregulation of SOD‑2 contributes to cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Liu B; Han X; Li Y; Wang W; Zhang Q; Lv P; Xing L; Shen H; Zhang X
Oncol Rep; 2019 Oct; 42(4):1497-1506. PubMed ID: 31364751
[TBL] [Abstract][Full Text] [Related]
8. Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma.
Qie S; Yoshida A; Parnham S; Oleinik N; Beeson GC; Beeson CC; Ogretmen B; Bass AJ; Wong KK; Rustgi AK; Diehl JA
Nat Commun; 2019 Mar; 10(1):1296. PubMed ID: 30899002
[TBL] [Abstract][Full Text] [Related]
9. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis.
Li L; Song D; Qi L; Jiang M; Wu Y; Gan J; Cao K; Li Y; Bai Y; Zheng T
Cancer Lett; 2021 Nov; 520():143-159. PubMed ID: 34256094
[TBL] [Abstract][Full Text] [Related]
11. Targeting leucine-rich PPR motif-containing protein/LRPPRC by 5,7,4'-trimethoxyflavone suppresses esophageal squamous cell carcinoma progression.
Liu H; Zhou Y; Fredimoses M; Niu P; Ge Y; Wu R; Liu T; Li P; Shi Y; Shi Y; Liu K; Dong Z
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131966. PubMed ID: 38697422
[TBL] [Abstract][Full Text] [Related]
12. Alpinumisoflavone triggers GSDME-dependent pyroptosis in esophageal squamous cell carcinomas.
Zhang B; Zhu WY; Tian H; Zhang HR
Anat Rec (Hoboken); 2021 Feb; 304(2):323-332. PubMed ID: 32396690
[TBL] [Abstract][Full Text] [Related]
13. miR-140-3P Induces Chemotherapy Resistance in Esophageal Carcinoma by Targeting the NFYA-MDR1 Axis.
Song B; Liu X; Dong H; Roy R
Appl Biochem Biotechnol; 2023 Feb; 195(2):973-991. PubMed ID: 36255597
[TBL] [Abstract][Full Text] [Related]
14. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
Zhao Y; Wang Y; Xing G
Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.
Li M; He XY; Zhang ZM; Li S; Ren LH; Cao RS; Feng YD; Ji YL; Zhao Y; Shi RH
World J Gastroenterol; 2015 Mar; 21(11):3245-55. PubMed ID: 25805931
[TBL] [Abstract][Full Text] [Related]
17. The CADM2/Akt pathway is involved in the inhibitory effect of miR-21-5p downregulation on proliferation and apoptosis in esophageal squamous cell carcinoma cells.
Li X; Chen D; Li M; Gao X; Shi G; Zhao H
Chem Biol Interact; 2018 May; 288():76-82. PubMed ID: 29680210
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.
Wang F; Ding X; Wang T; Shan Z; Wang J; Wu S; Chi Y; Zhang Y; Lv Z; Wang L; Fan Q
PLoS One; 2017; 12(4):e0174276. PubMed ID: 28406985
[TBL] [Abstract][Full Text] [Related]
19. Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer.
Roy SS; Gonugunta VK; Bandyopadhyay A; Rao MK; Goodall GJ; Sun LZ; Tekmal RR; Vadlamudi RK
Oncogene; 2014 Jul; 33(28):3707-16. PubMed ID: 23975430
[TBL] [Abstract][Full Text] [Related]
20. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
